Clinical centre Kragujevac

Kragujevac 34000

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer Disease, Multiple Sclerosis, Relapsing-Remitting, Schizophrenia

Studies at this site

• Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia — Stopped early
• Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One — Completed